Corcept Therapeutics Incorporated ( CORT) - Key Metrics
CORT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.95 | $0.23 | $0.37 | $0.37 |
| 2025Q3 | $2.01 | $0.19 | $0.53 | $0.53 |
| 2025Q2 | $1.87 | $0.34 | $0.42 | $0.42 |
| 2025Q1 | $1.51 | $0.19 | $0.05 | $0.05 |
CORT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 37.20 |
| 2025Q3 | ? | 111.13 |
| 2025Q2 | ? | 54.35 |
| 2025Q1 | ? | 146.53 |
CORT
Price: $82.75
52 week price:
Earnings Per Share: 0.35 USD
P/E Ratio: 149
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 611800
Ebitda: 13.7 millionMarket Capitalization: 7.8 billion